Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
08/3/2022 |
Chief Risk Officer
Trans History: 7
|
Chief Risk Officer | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,800 | $40.95 | 6,406 |
08/3/2022 |
Executive Vice President
Trans History: 55
|
Executive Vice President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,500 | $40.95 | 52,392 |
08/3/2022 |
President
Trans History: 218
|
President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $40.95 | 83,489 |
07/28/2022 |
Senior Vice President
Trans History: 118
|
Senior Vice President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | -- | $39.22 | 437 |
07/28/2022 |
Director, Chief Executive Officer
Trans History: 320
|
Director, Chief Executive Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1 | $39.22 | 2,761 |
07/5/2022 |
Director
Trans History: 43
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 20,605 |
07/5/2022 |
Director
Trans History: 129
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 5,121 |
07/5/2022 |
President
Trans History: 218
|
President | Form 4 | Other acquisition or disposition | -- | -- | 0 |
06/30/2022 |
Director
Trans History: 66
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 570 | $35.62 | 18,209 |
06/30/2022 |
Director
Trans History: 14
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 504 | $35.62 | 2,609 |
Pagination
- * Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.